Atyr Pharma Inc (NASDAQ:ATYR)’s traded shares stood at 1.85 million during the last session, with the company’s beta value hitting 0.80. At the close of trading, the stock’s price was $3.80, to imply an increase of 1.33% or $0.05 in intraday trading. The ATYR share’s 52-week high remains $4.66, putting it -22.63% down since that peak but still an impressive 62.63% since price per share fell to its 52-week low of $1.42.
Atyr Pharma Inc (NASDAQ:ATYR) trade information
After registering a 1.33% upside in the last session, Atyr Pharma Inc (ATYR) has traded red over the past five days. The 5-day price performance for the stock is 26.67%, and 7.95% over 30 days. With these gigs, the year-to-date price performance is 4.97%.
ATYR Dividends
Atyr Pharma Inc has its next earnings report out in June. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
We also have Federated Hermes Equity Funds-Federated Hermes Kaufmann Fund and Federated Hermes Equity Funds-Federated Hermes Kaufmann Small Cap Fund as the top two Mutual Funds with the largest holdings of the Atyr Pharma Inc (ATYR) shares. Going by data provided on Jan 31, 2025 , Federated Hermes Equity Funds-Federated Hermes Kaufmann Fund holds roughly 7.85 shares. This is just over 8.82% of the total shares, with a market valuation of $29.83 million. Data from the same date shows that the other fund manager holds a little less at 6.62, or 7.44% of the shares, all valued at about 25.16 million.
